Congress Reaches VA Spending Deal
Republicans and Democrats have agreed on an emergency spending bill to end the budget crisis in the Department of Veterans Affairs (VA). According to the AP, the package includes $3.9 billion that will help prevent a disruption in medical care for veterans as well as money for core VA health programs. Of the funding, $2.1 billion over 6 months will go to continue funding the Choice program. Veterans' groups had protested the original House plan, which they felt would lead to too much privatization.
Full Course of Antibiotics
A new opinion piece in BMJ is calling into question the widely held belief that patients must take the full course of antibiotics. The directive to finish the full course is not actually grounded in science, and may have helped create the current resistance problem, reported The Washington Post. A number of current studies are trying to determine whether the full course is necessary or if there is a shorter time period that patients can take antibiotics safely. Already, some studies have found that for some diseases and infections, 1 day of drugs is often sufficient and a full week is overkill.
Alabama Ends Medicaid Managed Care Proposal
A long-running plan to shift Alabama’s Medicaid program to managed care has come to an end. State officials have run into issues when it became uncertain if federal officials would maintain Medicaid funding. The overhaul was supposed to move some of the state’s Medicaid patients to managed care in the hope of controlling costs while improving outcomes. The state also decided to end the shift after receiving promises from the Trump administration that it will be reforming Medicaid to allow states more flexibility.
Unmet Needs Remain in Secondary AML Following Treatment With HMAs
January 18th 2025The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated with hypomethylating agents (HMAs) for myeloid neoplasms such as myelodysplastic syndromes.
Read More
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More